M.D. Sass Investors Services, Inc. Charles River Laboratories International, Inc. Transaction History

M.D. Sass Investors Services, Inc.

$1.24 Billion
Q3 2024

A detailed history of M.D. Sass Investors Services, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, M.D. Sass Investors Services, Inc. holds 321,172 shares of CRL stock, worth $59.8 Million. This represents 5.09% of its overall portfolio holdings.

Number of Shares

321,172

Previous 308,945 3.96%

Holding current value

$59.8 Million

Previous $63.8 Million 0.87%

% of portfolio

5.09%

Previous 4.93%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$187.96 - $245.29 $2.3 Million - $3 Million	12,227 Added 3.96%	321,172 $63.3 Million
Q2 2024 Aug 13, 2024	BUY	$206.39 - $268.73 $32.9 Million - $42.9 Million	159,492 Added 106.72%	308,945 $63.8 Million
Q1 2024 May 15, 2024	SELL	$203.52 - $273.43 $6.46 Million - $8.68 Million	-31,733 Reduced 17.51%	149,453 $40.5 Million
Q4 2023 Feb 14, 2024	SELL	$164.52 - $238.84 $537,651 - $780,529	-3,268 Reduced 1.77%	181,186 $42.8 Million
Q3 2023 Nov 14, 2023	BUY	$194.44 - $217.61 $1.75 Million - $1.96 Million	8,995 Added 5.13%	184,454 $36.1 Million
Q2 2023 Aug 10, 2023	BUY	$183.71 - $210.25 $4.65 Million - $5.32 Million	25,288 Added 16.84%	175,459 $36.9 Million
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $3.86 Million - $5.23 Million	20,118 Added 15.47%	150,171 $30.3 Million
Q4 2022 Feb 13, 2023	SELL	$197.11 - $250.07 $1.65 Million - $2.09 Million	-8,361 Reduced 6.04%	130,053 $28.3 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $25.3 Million - $34.7 Million	138,414 New	138,414 $27.2 Million
Q1 2021 May 17, 2021	SELL	$249.67 - $299.48 $9.95 Million - $11.9 Million	-39,841 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$222.0 - $252.62 $3.9 Million - $4.44 Million	-17,576 Reduced 30.61%	39,841 $9.96 Million
Q3 2020 Feb 03, 2021	SELL	$175.56 - $226.45 $2.52 Million - $3.24 Million	-14,328 Reduced 19.97%	57,417 $13 Million
Q2 2020 Aug 10, 2020	SELL	$118.84 - $189.72 $1.71 Million - $2.73 Million	-14,379 Reduced 16.7%	71,745 $12.5 Million
Q1 2020 May 06, 2020	BUY	$98.9 - $178.34 $941,824 - $1.7 Million	9,523 Added 12.43%	86,124 $10.9 Million
Q4 2019 Jan 30, 2020	SELL	$126.05 - $152.76 $3 Million - $3.63 Million	-23,793 Reduced 23.7%	76,601 $11.7 Million
Q3 2019 Nov 14, 2019	BUY	$125.07 - $143.67 $6.76 Million - $7.76 Million	54,014 Added 116.46%	100,394 $13.3 Million
Q2 2019 Aug 13, 2019	BUY	$123.4 - $148.55 $5.72 Million - $6.89 Million	46,380 New	46,380 $6.58 Million

Others Institutions Holding CRL

# of Institutions

695

Shares Held

52.2M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.48B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M.D. Sass Investors Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on M.D. Sass Investors Services, Inc. with notifications on news.

Account

M.D. Sass Investors Services, Inc. Charles River Laboratories International, Inc. Transaction History